Clots Lungs
Sort by
1 items
-
World - The Guardian
‘Amazing’ trial shows drug combination stops lung cancer advancing for longer
Exclusive: Global trial finds treatment with amivantamab and lazertinib halts progression for average of 23.7 months. Doctors are hailing “amazing” trial results that show a new drug combination ...Yesterday